1. Freedom of Information Summary. Prascend tablets, pergolide mesylate, for the control of clinical signs associated with pituitary pars intermedia dysfunction (equine Cushing’s disease) in horses. Original New Animal Drug Application;Andrews;NADA,2011
2. Cortisol, adrenocorticotropic hormone, serotonin, adrenaline and noradrenaline serum concentrations in relation to disease and stress in the horse;Ayala;Research in Veterinary Science,2012
3. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction;Copas;Equine Veterinary Journal,2012
4. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease);Donaldson;Journal of Veterinary Internal Medicine,2002
5. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis;Donaldson;Journal of the American Veterinary Medical Association,2004